Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership3,388 shares
Latest Disclosed Value $ 446,339
Us Bancorp \de\ reports 1.28% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 3,388 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $446,339 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 3,432 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -1.28% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,388 -44 -1.28 446 -8.23 0.0002
2026-01-30 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,432 -81 -2.31 487 -1.42 0.0006
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,513 -589 -14.36 493 -4.27 0.0006
2025-07-24 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,102 373 10.00 516 25.00 0.0006
2025-05-08 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,729 -446 -10.68 412 -27.59 0.0006
2025-02-05 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,175 311 8.05 570 27.87 0.0007
2024-10-28 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,864 -1,709 -30.67 445 -41.98 0.0006
2024-08-07 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,573 614 12.38 767 12.30 0.0010
2024-05-08 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,959 -926 -15.73 684 -11.87 0.0010
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,885 522 9.73 775 28.52 0.0011
2023-11-03 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,363 -5,606 -51.11 603 -41.68 0.0010
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,969 -12,669 -53.60 1,034 -56.77 0.0017
2023-05-09 2023-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 23,638 696 3.03 2,393 -12.70 0.0040
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 22,942 -6,229 -21.35 2,740 -11.61 0.0049
2022-10-27 2022-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 29,171 -2,040 -6.54 3,100 1.87 0.0064
2022-08-01 2022-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 31,211 96 0.31 3,043 4.32 0.0059
2022-05-11 2022-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 31,115 9,524 44.11 2,917 58.62 0.0049
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 21,591 -8,830 -29.03 1,839 -36.98 0.0029
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 30,421 -413 -1.34 2,918 -2.77 0.0055
2021-08-05 2021-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 30,834 1,740 5.98 3,001 6.08 0.0056
2021-04-28 2021-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 29,094 7,366 33.90 2,829 35.88 0.0057
2021-02-04 2020-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 21,728 3,549 19.52 2,082 19.11 0.0045
2020-11-10 2020-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 18,179 13,704 306.23 1,748 220.15 0.0043
2020-08-07 2020-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 4,475 655 17.15 546 65.45 0.0014
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 3,820 11 0.29 330 -19.51 0.0010
2020-02-04 2019-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 3,809 685 21.93 410 45.91 0.0010
2019-11-08 2019-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 3,124 250 8.70 281 15.16 0.0008
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 2,874 -12 -0.42 244 -3.94 0.0007
2019-05-08 2019-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 2,886 1,609 126.00 254 179.12 0.0007
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 1,277 479 60.03 91 -8.08 0.0003
2018-10-31 2018-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 798 28 3.64 99 32.00 0.0003
2018-08-08 2018-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 770 54 7.54 75 27.12 0.0002
2018-05-08 2018-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 716 318 79.90 59 90.32 0.0002
2018-02-02 2017-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 398 -534 -57.30 31 -45.61 0.0001
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 932 326 53.80 57 103.57 0.0002
2017-07-19 2017-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 606 314 107.53 28 133.33 0.0001
2017-05-03 2017-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 292 -173 -37.20 12 -33.33 0.0000
2017-02-08 2016-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 465 440 1,760.00 18 1,700.00 0.0001
2016-11-04 2016-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 25 -503 -95.27 1 -95.83 0.0000
2016-08-10 2016-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 528 -458 -46.45 24 -38.46 0.0001
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 986 -1,577 -61.53 39 -73.10 0.0002
2016-02-10 2015-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 2,563 1,437 127.62 145 222.22 0.0006
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 1,126 -293 -20.65 45 -33.82 0.0002
2015-08-10 2015-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 1,419 73 5.42 68 25.93 0.0003
2015-05-08 2015-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 1,346 1,146 573.00 54 1,250.00 0.0002
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 0 0.00 4 33.33 0.0000
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 0 0.00 3 0.00 0.0000
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 0 0.00 3 0.00 0.0000
2014-05-14 2014-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 0 0.00 3 50.00 0.0000
2014-02-13 2013-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 0 0.00 2 0.00 0.0000
2013-11-07 2013-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 0 0.00 2 -33.33 0.0000
2013-08-09 2013-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 200 200 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.